Sanofi
|
SNY |
4 Q |
-4.65 % |
-4.65 % |
3.35 % |
3.35 % |
Novartis Ag
|
NVS |
4 Q |
-9.97 % |
-9.97 % |
113.57 % |
113.57 % |
Astrazeneca Plc
|
AZN |
4 Q |
3.29 % |
3.29 % |
81.02 % |
81.02 % |
Takeda Pharmaceutical Company Limited
|
TAK |
1 Q |
4.53 % |
4.53 % |
-55.09 % |
-55.09 % |
Johnson and Johnson
|
JNJ |
1 Q |
2.39 % |
-2.78 % |
237.91 % |
220.58 % |
Merck and Co Inc
|
MRK |
1 Q |
-1.56 % |
-0.61 % |
6.67 % |
35.82 % |
Pfizer Inc
|
PFE |
1 Q |
-7.82 % |
-22.79 % |
-4.8 % |
611.24 % |
Abbvie Inc
|
ABBV |
1 Q |
8.39 % |
-11.65 % |
-6.05 % |
-5704.35 % |
Eli Lilly And Company
|
LLY |
1 Q |
45.17 % |
-5.94 % |
23.02 % |
-37.43 % |
Bristol myers Squibb Company
|
BMY |
1 Q |
-5.6 % |
-9.24 % |
-120.68 % |
3139.47 % |
Amgen Inc
|
AMGN |
4 Q |
10.86 % |
6.86 % |
-18.25 % |
-77.84 % |
Gilead Sciences Inc
|
GILD |
1 Q |
-0.28 % |
-11.92 % |
-131.53 % |
-26.25 % |
Teva Pharmaceutical Industries Limited
|
TEVA |
1 Q |
1.89 % |
-8.04 % |
-152.51 % |
-179.71 % |
Viatris Inc
|
VTRS |
1 Q |
-11.17 % |
-7.76 % |
-2770.76 % |
488.96 % |
Regeneron Pharmaceuticals Inc
|
REGN |
1 Q |
-3.7 % |
-20.07 % |
12.01 % |
-11.88 % |
Organon and Co
|
OGN |
1 Q |
-6.72 % |
-4.96 % |
-56.72 % |
-20.18 % |
Beigene Ltd
|
ONC |
1 Q |
48.83 % |
- |
-100.51 % |
- |
Legend Biotech Corporation
|
LEGN |
4 Q |
217.56 % |
217.56 % |
34.19 % |
34.19 % |
Morphosys Ag
|
MOR |
4 Q |
-14.37 % |
-14.37 % |
25.6 % |
25.6 % |
Arvinas Inc
|
ARVN |
1 Q |
646.25 % |
218.92 % |
-219.45 % |
-283.81 % |
Blueprint Medicines Corporation
|
BPMC |
1 Q |
55.45 % |
2.08 % |
-99.44 % |
-100.99 % |
Biocryst Pharmaceuticals Inc
|
BCRX |
1 Q |
56.89 % |
10.64 % |
-100.09 % |
-100.12 % |
Tg Therapeutics Inc
|
TGTX |
1 Q |
90.4 % |
11.71 % |
-147.26 % |
-78.31 % |
Immunogen inc
|
IMGN |
3 Q |
637.72 % |
36.41 % |
-139.54 % |
-823.82 % |
Zai Lab Limited
|
ZLAB |
1 Q |
22.19 % |
-2.37 % |
-9.41 % |
-40.7 % |
Myovant Sciences Ltd
|
MYOV |
4 Q |
84.11 % |
-4.38 % |
-9.17 % |
26.32 % |
Travere Therapeutics Inc
|
TVTX |
1 Q |
97.54 % |
9.29 % |
-69.7 % |
-31.59 % |
Mannkind Corporation
|
MNKD |
1 Q |
18.25 % |
2.06 % |
23.78 % |
77.28 % |
Evolus Inc
|
EOLS |
1 Q |
14.03 % |
-63.36 % |
44.11 % |
178.19 % |
Esperion Therapeutics Inc
|
ESPR |
1 Q |
-52.81 % |
-5.96 % |
-166.3 % |
89.77 % |
Revance Therapeutics Inc
|
RVNC |
3 Q |
5.47 % |
-8.43 % |
12605 % |
1.71 % |
Cytomx Therapeutics Inc
|
CTMX |
1 Q |
22.8 % |
33.66 % |
70.58 % |
24.63 % |
Puma Biotechnology Inc
|
PBYI |
1 Q |
5.12 % |
-22.12 % |
-161.77 % |
-84.59 % |
Deciphera Pharmaceuticals Inc
|
DCPH |
1 Q |
34.55 % |
-6.82 % |
-9.12 % |
-4.46 % |
Xencor Inc
|
XNCR |
1 Q |
104.61 % |
-38 % |
-34.38 % |
5.26 % |
Day One Biopharmaceuticals Inc
|
DAWN |
1 Q |
- |
5.32 % |
- |
-8.62 % |
Casi Pharmaceuticals inc
|
CASI |
4 Q |
-15.77 % |
-15.77 % |
49.5 % |
49.5 % |
Protagonist Therapeutics inc
|
PTGX |
1 Q |
-88.89 % |
-83.4 % |
-105.62 % |
-108.85 % |
Merus N v
|
MRUS |
1 Q |
235.76 % |
189.8 % |
179.99 % |
211.98 % |
Adc Therapeutics Sa
|
ADCT |
1 Q |
27.59 % |
36.21 % |
-17.17 % |
25.63 % |
Syndax Pharmaceuticals Inc
|
SNDX |
1 Q |
- |
160.96 % |
17.19 % |
-9.9 % |
G1 Therapeutics Inc
|
GTHX |
2 Q |
-60.97 % |
14.3 % |
-162.79 % |
-46.48 % |
Mirati Therapeutics Inc
|
MRTX |
3 Q |
201.97 % |
19.8 % |
-6.72 % |
-8.48 % |
Kura Oncology Inc
|
KURA |
1 Q |
- |
-73.82 % |
15.96 % |
198.84 % |
Macrogenics Inc
|
MGNX |
1 Q |
44.9 % |
-31.83 % |
-21.37 % |
166.1 % |
Journey Medical Corp
|
DERM |
1 Q |
0.84 % |
-3.53 % |
-60.99 % |
-367.78 % |
Nektar Therapeutics
|
NKTR |
1 Q |
-51.66 % |
-64.15 % |
38.26 % |
-800.76 % |
Gossamer Bio Inc
|
GOSS |
1 Q |
- |
5.44 % |
-12.62 % |
10.93 % |
Affimed N v
|
AFMD |
4 Q |
-79.99 % |
-79.99 % |
23.18 % |
23.18 % |
Whitehawk Therapeutics Inc
|
WHWK |
1 Q |
33.48 % |
- |
-499.23 % |
- |
Xilio Therapeutics inc
|
XLO |
1 Q |
- |
69.95 % |
-22.89 % |
1.31 % |
Aravive Inc
|
ARAV |
3 Q |
-44.39 % |
116.33 % |
-235.52 % |
17.87 % |
Tonix Pharmaceuticals Holding Corp
|
TNXP |
1 Q |
-2.14 % |
-5.93 % |
12.65 % |
-23.88 % |
Abeona Therapeutics Inc
|
ABEO |
1 Q |
55.4 % |
28.05 % |
-61.91 % |
29.44 % |
Bolt Biotherapeutics Inc
|
BOLT |
1 Q |
-76.83 % |
1.3758496861617E+17 % |
2.12 % |
-30.72 % |
Oncternal Therapeutics Inc
|
ONCT |
3 Q |
175.98 % |
-38.33 % |
-14.18 % |
-1.11 % |
Therapeuticsmd Inc
|
TXMD |
1 Q |
67.95 % |
67.95 % |
-40.09 % |
-40.09 % |
Northwest Biotherapeutics Inc
|
NWBO |
1 Q |
32.04 % |
62.34 % |
3.86 % |
-31.19 % |
Vaccinex Inc
|
VCNX |
4 Q |
- |
-118.88 % |
-59.25 % |
-41.14 % |
Lyra Therapeutics Inc
|
LYRA |
1 Q |
-65.6 % |
-12.44 % |
-61.93 % |
-22.15 % |
Adagene Inc
|
ADAG |
4 Q |
-99.43 % |
-99.43 % |
76.41 % |
76.41 % |
Chimerix Inc
|
CMRX |
4 Q |
1325 % |
119.23 % |
26.39 % |
0.33 % |
Essa Pharma inc
|
EPIX |
1 Q |
- |
- |
-29.09 % |
-25.28 % |
Repare Therapeutics Inc
|
RPTX |
1 Q |
-100 % |
- |
-328.26 % |
4.79 % |
Janux Therapeutics Inc
|
JANX |
1 Q |
-100 % |
- |
59.27 % |
16.28 % |
Checkpoint Therapeutics inc
|
CKPT |
1 Q |
- |
- |
2.44 % |
-61.2 % |
Oric Pharmaceuticals Inc
|
ORIC |
1 Q |
- |
- |
20.03 % |
-17.31 % |
Nuvalent Inc
|
NUVL |
1 Q |
- |
- |
90.15 % |
13.13 % |
Cns Pharmaceuticals Inc
|
CNSP |
1 Q |
-100 % |
-100 % |
21.34 % |
35.42 % |
Spyre Therapeutics Inc
|
SYRE |
1 Q |
- |
- |
2.09 % |
-20.47 % |
Prelude Therapeutics Inc
|
PRLD |
1 Q |
- |
-100 % |
2.08 % |
11.67 % |
Olema Pharmaceuticals Inc
|
OLMA |
1 Q |
- |
- |
-1.88 % |
-9.47 % |
Cadrenal Therapeutics Inc
|
CVKD |
1 Q |
- |
- |
- |
99.94 % |
Erasca Inc
|
ERAS |
1 Q |
- |
- |
-11.57 % |
-3.93 % |
Sagimet Biosciences inc
|
SGMT |
1 Q |
- |
- |
174.19 % |
12.19 % |
Cogent Biosciences Inc
|
COGT |
1 Q |
- |
- |
23.37 % |
5.98 % |
Cytodyn inc
|
CYDY |
1 Q |
- |
- |
-60.08 % |
-0.21 % |
Atossa Therapeutics Inc
|
ATOS |
1 Q |
- |
- |
14.29 % |
5.85 % |
Abvc Biopharma Inc
|
ABVC |
1 Q |
-100 % |
-100 % |
-71.97 % |
603.19 % |
Zentalis Pharmaceuticals Inc
|
ZNTL |
1 Q |
-100 % |
-100 % |
-580.87 % |
1.7 % |
Allarity Therapeutics Inc
|
ALLR |
1 Q |
- |
- |
-25.19 % |
-63.34 % |
Werewolf Therapeutics Inc
|
HOWL |
1 Q |
-100 % |
- |
11.71 % |
-11.33 % |
Rapt Therapeutics Inc
|
RAPT |
1 Q |
- |
- |
-43.76 % |
-67.76 % |
Atea Pharmaceuticals Inc
|
AVIR |
1 Q |
- |
- |
-12.49 % |
8.62 % |
Cellectar Biosciences Inc
|
CLRB |
1 Q |
- |
- |
-75.21 % |
180.38 % |
Alx Oncology Holdings Inc
|
ALXO |
1 Q |
- |
- |
-13.57 % |
5.46 % |
Mural Oncology Plc
|
MURA |
1 Q |
- |
- |
7.18 % |
-3.32 % |
Immuneering Corporation
|
IMRX |
1 Q |
- |
- |
5.16 % |
-16.65 % |
Verastem Inc
|
VSTM |
1 Q |
- |
- |
53.86 % |
-19.28 % |
Genprex Inc
|
GNPX |
1 Q |
- |
- |
-33.58 % |
-13.95 % |
Medicinova Inc
|
MNOV |
1 Q |
- |
- |
3.98 % |
1.76 % |
Ideaya Biosciences Inc
|
IDYA |
1 Q |
- |
-100 % |
82.4 % |
-44.61 % |
Nanoviricides inc
|
NNVC |
1 Q |
- |
- |
19.54 % |
9.34 % |
Shattuck Labs Inc
|
STTK |
1 Q |
-100 % |
- |
-25.95 % |
-26.64 % |
Mineralys Therapeutics Inc
|
MLYS |
1 Q |
- |
- |
33.97 % |
-13.76 % |
Biomea Fusion Inc
|
BMEA |
1 Q |
- |
- |
-100 % |
-100 % |
Nextcure Inc
|
NXTC |
1 Q |
- |
- |
-35.84 % |
-5.4 % |
Lantern Pharma Inc
|
LTRN |
1 Q |
- |
- |
-16.62 % |
-22.78 % |
I mab
|
IMAB |
4 Q |
-100 % |
-100 % |
-89.23 % |
-89.23 % |
Panbela Therapeutics Inc
|
PBLA |
3 Q |
- |
- |
-8.42 % |
0.46 % |
Syros Pharmaceuticals Inc
|
SYRS |
3 Q |
-100 % |
- |
-84.07 % |
-72.58 % |
Viracta Therapeutics Inc
|
VIRX |
3 Q |
- |
- |
-16.25 % |
7.36 % |
Effector Therapeutics Inc
|
EFTR |
1 Q |
- |
- |
-11.78 % |
-3.24 % |
Nucana Plc
|
NCNA |
4 Q |
- |
- |
-13.71 % |
-13.71 % |
Biophytis Sa
|
BPTS |
4 Q |
- |
- |
-45.51 % |
-45.51 % |
Kinnate Biopharma Inc
|
KNTE |
3 Q |
- |
- |
-0.01 % |
-3.71 % |
Rain Oncology Inc
|
RAIN |
3 Q |
- |
- |
-61.01 % |
-68.12 % |
Eqrx Inc
|
EQRX |
3 Q |
- |
- |
-2.89 % |
13.26 % |
Innovation Pharmaceuticals Inc
|
CTIX |
3 Q |
- |
- |
-38.38 % |
29.22 % |
Theseus Pharmaceuticals Inc
|
THRX |
3 Q |
- |
- |
-8.42 % |
-8.79 % |
Oncosec Medical Incorporated
|
ONCS |
4 Q |
- |
- |
-30.75 % |
-14.89 % |
Tyme Technologies Inc.
|
TYME |
2 Q |
- |
- |
9.54 % |
-4.69 % |
Iterum Therapeutics Plc
|
ITRM |
1 Q |
42.23 % |
- |
-31.12 % |
-25.69 % |